Primary Site >> Liver Cancer
Gene >> PTPN11
| 1. | |||||||||||
| Journal: | Oncogene. 2008 Jun 5;27(25):3508-15. | ||||||||||
| Title: | Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors. | ||||||||||
| Author: | Miyamoto, D|Miyamoto, M|Takahashi, A|Yomogita, Y|Higashi, H|Kondo, S|Hatakeyama, M | ||||||||||
| PMID: | 18223690 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Cell. 2011 May 17;19(5):629-39. | ||||||||||
| Title: | Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. | ||||||||||
| Author: | Bard-Chapeau, Emilie A|Li, Shuangwei|Ding, Jin|Zhang, Sharon S|Zhu, Helen H|Princen, Frederic|Fang, Diane D|Han, Tao|Bailly-Maitre, Beatrice|Poli, Valeria|Varki, Nissi M|Wang, Hongyang|Feng, Gen-Sheng | ||||||||||
| PMID: | 21575863 | ||||||||||
| 3. | |||||||||||
| Journal: | J Cancer Res Clin Oncol. 2012 Apr;138(4):637-46. | ||||||||||
| Title: | The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma. | ||||||||||
| Author: | Jiang, Chengying|Hu, Fangke|Tai, Yanhong|Du, Jingli|Mao, Beibei|Yuan, Zengqiang|Wang, Yan|Wei, Lixin | ||||||||||
| PMID: | 22228034 | ||||||||||
| 4. | |||||||||||
| Journal: | PLoS One. 2014 Sep 8;9(9):e106841. | ||||||||||
| Title: | Functional short tandem repeat polymorphism of PTPN11 and susceptibility to hepatocellular carcinoma in Chinese populations. | ||||||||||
| Author: | Zhao, Xiankun|Hu, Shuxiang|Wang, Lu|Zhang, Qing|Zhu, Xiaodan|Zhao, Hua|Wang, Chaoqun|Tao, Ruiyang|Guo, Siping|Wang, Jing|Xu, Jiejie|He, Yan|Gao, Yuzhen | ||||||||||
| PMID: | 25198338 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncotarget. 2015 Apr 20;6(11):9355-69. | ||||||||||
| Title: | Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development. | ||||||||||
| Author: | Deng, Rong|Zhao, Xian|Qu, YingYing|Chen, Cheng|Zhu, Changhong|Zhang, Hailong|Yuan, Haihua|Jin, Hui|Liu, Xin|Wang, Yanli|Chen, Qin|Huang, Jian|Yu, Jianxiu | ||||||||||
| PMID: | 25823821 | ||||||||||
| 6. | |||||||||||
| Journal: | J Hepatol. 2015 Sep;63(3):651-60. | ||||||||||
| Title: | PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients. | ||||||||||
| Author: | Han, Tao|Xiang, Dai-Min|Sun, Wen|Liu, Na|Sun, Huan-Lin|Wen, Wen|Shen, Wei-Feng|Wang, Ruo-Yu|Chen, Cheng|Wang, Xue|Cheng, Zhuo|Li, Heng-Yu|Wu, Meng-Chao|Cong, Wen-Ming|Feng, Gen-Sheng|Ding, Jin|Wang, Hong-Yang | ||||||||||
| PMID: | 25865556 | ||||||||||
| 7. | |||||||||||
| Journal: | J Cell Mol Med. 2015 Sep;19(9):2075-83. | ||||||||||
| Title: | Functions of Shp2 in cancer. | ||||||||||
| Author: | Zhang, Jie|Zhang, Fei|Niu, Ruifang | ||||||||||
| PMID: | 26088100 | ||||||||||
| 8. | |||||||||||
| Journal: | Cell Rep. 2016 Dec 13;17(11):2979-2993. | ||||||||||
| Title: | Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. | ||||||||||
| Author: | Luo, Xiaolin|Liao, Rui|Hanley, Kaisa L|Zhu, Helen He|Malo, Kirsten N|Hernandez, Carolyn|Wei, Xufu|Varki, Nissi M|Alderson, Nazilla|Chu, Catherine|Li, Shuangwei|Fan, Jia|Loomba, Rohit|Qiu, Shuang-Jian|Feng, Gen-Sheng | ||||||||||
| PMID: | 27974211 | ||||||||||
| 9. | |||||||||||
| Journal: | Eur J Pharmacol. 2017 Feb 5;796:233-241. | ||||||||||
| Title: | Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells. | ||||||||||
| Author: | Ren, Xuanqi|Wang, Cui|Xie, Binbin|Hu, Linfeng|Chai, Hui|Ding, Lei|Tang, Lihua|Xia, Yongliang|Dou, Xiaobing | ||||||||||
| PMID: | 27894814 | ||||||||||
| 10. | |||||||||||
| Journal: | Oncotarget. 2017 Apr 18;8(16):27263-27276. | ||||||||||
| Title: | SHP2 is induced by the HBx-NF-kappaB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. | ||||||||||
| Author: | Kang, Hyo Jeong|Chung, Dal-Hee|Sung, Chang Ohk|Yoo, Su Hyun|Yu, Eunsil|Kim, Nayoung|Lee, Sy-Hye|Song, Ji-Young|Kim, Chong Jai|Choi, Jene | ||||||||||
| PMID: | 28460481 | ||||||||||
| 11. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2017 Jul 27;36(1):99. | ||||||||||
| Title: | miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma. | ||||||||||
| Author: | Jiang, Chunlin|Long, Jianting|Liu, Baoxian|Xu, Ming|Wang, Wei|Xie, Xiaoyan|Wang, Xiaolin|Kuang, Ming | ||||||||||
| PMID: | 28750679 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncotarget. 2017 Nov 20;8(69):113734-113748. | ||||||||||
| Title: | Dietary quercetin potentiates the antiproliferative effect of interferon-alpha in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase. | ||||||||||
| Author: | Igbe, Ighodaro|Shen, Xiao-Fei|Jiao, Wei|Qiang, Zhe|Deng, Teng|Li, Sheng|Liu, Wan-Li|Liu, Han-Wei|Zhang, Guo-Lin|Wang, Fei | ||||||||||
| PMID: | 29371942 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Lett. 2018 Jun 1;423:113-126. | ||||||||||
| Title: | Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling. | ||||||||||
| Author: | Long, Jianting|Jiang, Chunlin|Liu, Baoxian|Dai, Qiangsheng|Hua, Ruixi|Chen, Cui|Zhang, Bing|Li, Heping | ||||||||||
| PMID: | 29196128 | ||||||||||
| 14. | |||||||||||
| Journal: | J Hepatol. 2018 Jul;69(1):79-88. | ||||||||||
| Title: | Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic beta-Catenin, PIK3CA and MET. | ||||||||||
| Author: | Liu, Jacey J|Li, Yanjie|Chen, Wendy S|Liang, Yan|Wang, Gaowei|Zong, Min|Kaneko, Kota|Xu, Ruiyun|Karin, Michael|Feng, Gen-Sheng | ||||||||||
| PMID: | 29505847 | ||||||||||